Kenya

Novartis Coartem

Coartem is the first World Health Organization-prequalified fixed-dose, artemisinin-based combination therapy (ACT) antimalarial, approved by stringent regulatory authorities and on the WHO Model List of Essential Medicines. Coartem is fast-acting and cures over 97% of patients after a 3-day treatment course. Coartem combines artemether, a derivative of artemisinin (from the Chinese medicinal plant Artemisia annua), with a synthetic substance, lumefantrine, which has not been used as a monotherapy.

Mothers 2 Mothers Mentoring Program

Mothers 2 Mothers (M2M) provides education for South African HIV-positive pregnant women about how to prevent mother-to-child transmission of the disease and later mentor other HIV-positive pregnant women.

Merck Vaccine Network - Africa (MVN-A)

In support of the GAVI Alliance's mission of increasing children's access to vaccines and strengthening delivery systems in the world's poorest countries, the Merck Vaccine Network – Africa (MVN-A) program provides immunization program managers in Africa with hands-on training in vaccine management and immunization services.

Merck & Co., Inc. HIV/AIDS Programs - Africa

In 2009, with support from The Merck Company Foundation, the Earth Institute at Columbia University launched a community health worker training program to strengthen community health services for over 400,000 people in 10 African countries as part of the Millennium Villages project. The initiative aims to develop a professional cadre of 800 community health workers to fill a critical gap in primary healthcare provision for rural communities throughout Africa.

Medicines for Malaria Venture (MMV)

Seeks to discover, develop and deliver new antimalarial medicines suitable for use in developing countries.

Medical Mission Sisters

With funding assistance from Johnson & Johnson, the Medical Mission Sisters group cares for more than 1,000 people affected by HIV/AIDs in one of the poorest areas of Nairobi, Kenya. The group also runs a hospice facility and IV Rehydration Unit, distributes food to families with sick parents, and provides educational programs for deaf and handicapped youth.

Leprosy Elimination

Novartis is providing free treatment for leprosy patients worldwide through its multi-drug therapy.

J&J Health Care Training Fund

The Johnson & Johnson Health Care Training fund was started in 2004. It is a collaboration between J&J and i+solutions in the Netherlands which specializes in pharmaceutical supply chain management training in developing countries. Activities include: Training in 'Supply Chain Management of HIV/AIDS Medicines & Supplies'.

J&J - UCLA Management Development Institute

The Johnson & Johnson - UCLA Management Development Institute (MDI) was created in 2006 as an intensive one-week program designed to enhance the management skills of health care leaders of East and West African organizations devoted to the care, treatment and support of people and their families living with HIV/AIDS. Dr. Ernest O. Nyamato, director of services at Liverpool Voluntary Counseling & Testing (LVCT) care & treatment centers in Kenya, attended the program in 2006.

International Trachoma Initiative (ITI)

The International Trachoma Initiative (ITI) is the only organization dedicated solely to the elimination of blinding trachoma.

Pages